These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19890499)

  • 1. Molecule of the Month. TMC-207.
    Drug News Perspect; 2009 Sep; 22(7):421. PubMed ID: 19890499
    [No Abstract]   [Full Text] [Related]  

  • 2. [A diarylquinolone active against tuberculosis].
    Holzgrabe U; Bennack E
    Pharm Unserer Zeit; 2005; 34(3):183-4. PubMed ID: 15940948
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicine. New TB drug promises shorter, simpler treatment.
    Cohen J
    Science; 2004 Dec; 306(5703):1872. PubMed ID: 15591168
    [No Abstract]   [Full Text] [Related]  

  • 4. Shortening the treatment of tuberculosis.
    Mitchison DA
    Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148
    [No Abstract]   [Full Text] [Related]  

  • 5. Microbiology. TB--a new target, a new drug.
    Cole ST; Alzari PM
    Science; 2005 Jan; 307(5707):214-5. PubMed ID: 15653490
    [No Abstract]   [Full Text] [Related]  

  • 6. TMC-207.
    Tuberculosis (Edinb); 2008 Mar; 88(2):168-9. PubMed ID: 18486063
    [No Abstract]   [Full Text] [Related]  

  • 7. Minimising moxifloxacin resistance with tuberculosis.
    Drlica K; Zhao X; Kreiswirth B
    Lancet Infect Dis; 2008 May; 8(5):273-5. PubMed ID: 18471768
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prospects for design of novel antituberculosis drugs].
    Nikitin AV
    Antibiot Khimioter; 2006; 51(9-10):56-60. PubMed ID: 18030793
    [No Abstract]   [Full Text] [Related]  

  • 9. Public-private partnership tackles TB challenges in parallel.
    Webb S
    Nat Rev Drug Discov; 2009 Aug; 8(8):599-600. PubMed ID: 19644463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.
    Andries K; Verhasselt P; Guillemont J; Göhlmann HW; Neefs JM; Winkler H; Van Gestel J; Timmerman P; Zhu M; Lee E; Williams P; de Chaffoy D; Huitric E; Hoffner S; Cambau E; Truffot-Pernot C; Lounis N; Jarlier V
    Science; 2005 Jan; 307(5707):223-7. PubMed ID: 15591164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational use of moxifloxacin for tuberculosis treatment.
    Cox H; Ford N; Keshavjee S; McDermid C; von Schoen-Angerer T; Mitnick C; Goemaere E
    Lancet Infect Dis; 2011 Apr; 11(4):259-60. PubMed ID: 21453864
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primary resistance of Mycobacterium tuberculosis].
    Barranquero Arola M; Gorritxo Gil B; Goiriena de Gandarias J
    Rev Sanid Hig Publica (Madr); 1984; 58(11-12):1107-15. PubMed ID: 6443589
    [No Abstract]   [Full Text] [Related]  

  • 13. Tuberculosis drug resistance: summary report for 2003.
    Can Commun Dis Rep; 2004 May; 30(10):93-5. PubMed ID: 15174496
    [No Abstract]   [Full Text] [Related]  

  • 14. Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling.
    Gumbo T; Louie A; Deziel MR; Parsons LM; Salfinger M; Drusano GL
    J Infect Dis; 2004 Nov; 190(9):1642-51. PubMed ID: 15478070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ring-substituted quinolines as potential anti-tuberculosis agents.
    Vangapandu S; Jain M; Jain R; Kaur S; Singh PP
    Bioorg Med Chem; 2004 May; 12(10):2501-8. PubMed ID: 15110831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moxifloxacin.
    Tuberculosis (Edinb); 2008 Mar; 88(2):127-31. PubMed ID: 18486050
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sensitivity of Mycobacterium tuberculosis in our environment].
    Unzaga MJ; Sota M; Melero P; Berdonces P; Ezpeleta C; Cisterna R
    Enferm Infecc Microbiol Clin; 1996; 14(6):399-400. PubMed ID: 8756225
    [No Abstract]   [Full Text] [Related]  

  • 18. [Short-term chemotherapy of tuberculosis in Chile. Bacteriological considerations].
    Valenzuela P
    Rev Med Chil; 1983 Jul; 111(7):747-9. PubMed ID: 6440255
    [No Abstract]   [Full Text] [Related]  

  • 19. Infectious disease. Approval of novel TB drug celebrated--with restraint.
    Cohen J
    Science; 2013 Jan; 339(6116):130. PubMed ID: 23307714
    [No Abstract]   [Full Text] [Related]  

  • 20. Moxifloxacin for tuberculosis.
    Singh KP; Brown M; Murphy ME; Gillespie SH
    Lancet Infect Dis; 2012 Mar; 12(3):176; author reply 177-8. PubMed ID: 22361420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.